|
|
|
| Clinical Observation on Therapeutic Efficacy of Peiyuanjianpi Acupuncture and Medicine Prescription on Type 2 Diabetes Mellitus Complicated with Obesity |
| ZHU Hairui, LIU Jia |
| The Traditional Chinese Medicine Hospital of Chengde, Hebei Chengde 067000, China |
|
|
|
|
Abstract Objective: To observe the clinical effect of acupuncture and medicine combined with "Gubenpeiyuan, jianpihewei" in the treatment of obese type 2 diabetes.Methods: 80 obese patients with type 2 diabetes mellitus from March 2019 to March 2022 were selected and divided into 2 groups with 40 patients in each group according to the random number table method. The control group was given metformin hydrochloride tablets combined with miglitol tablets. Based on the control group, the treatment group was added with needle and drug combination therapy. Both groups were treated for 30 days (1 course). The differences of relevant observation indexes before and after treatment were compared between the two groups.Results: The total effective rate of the treatment group was higher than that of the control group (P<0.05). There were significant differences in BMI, FPG, FINS, HOMA-IR, TC, TG, and LDL-C between the two groups after treatment compared with before treatment (P<0.05), and the treatment group was superior to the control group (P<0.05). There was no obvious statistical difference in reducing WHR and IAI (P>0.05), indicating that there was no remarkable difference in the reduction of WHR and IAI between the treatment group and the control group.Conclusion: Acupuncture and medicine combined with "Gubenpeiyuan, jianpihewei" has definite clinical efficacy in the treatment of obesity-type 2 diabetes mellitus. It is effective in reducing body weight, reducing fat, restoring blood glucose level, and treating insulin resistance, especially in improving FINS, HDL-C, and reducing TC and LDL-C. The effect of reducing BMI, FPG, TG and HOMA-IR is worthy of affirmation, without side effects, and worthy of clinical application.
|
|
|
|
|
|
[1] 庞国明,倪青,张芳.2型糖尿病病症结合诊疗指南[J].中医杂志,2021,62(4):361-368.
[2] Yang W,Lu I.Weng,et al.Prevalence of diabetes among men and women in China[J].N Engl Med,2010,362(12):1090-1101.
[3] 井源,韩婷,董砚虎.2007年ADA第67届科学年会专题报道[J].实用糖尿病杂志,2008,4(5):8-11.
[4] 中华医学会糖尿病分会.中国2型糖尿病防治指南(2020年版)[J].中华糖尿病杂志,2021,13(4):315-409.
[5] 中华人民共和国卫生部疾病控制司.中国成人超重和肥胖症预防控制指南[M].北京:人民卫生出版社,2006.
[6] 郑筱萸.中药新药临床研究指导原则(试行)[M].北京:中国医药科技出版社,2002.
[7] 吕媛媛,马慧璇.二甲双胍联合罗格列酮治疗新诊断2型糖尿病患者胰岛功能影响[J].中国医药科学,2018,8(18):35-37.
[8] 黄帝内经素问.[M].北京:人民卫生出版社,1983.
[9] 贺璞玉,倪青.从脾探讨 2 型糖尿病病因病机[J].河北中医,2021,10(43):1738-1741.
[10] 唐·王焘.外台秘要[M].北京:人民卫生出版社,1987.
[11] Jang M H,Shin M C,Koo G S,etd.Acupuncture decreases nitricoxide synthase expression in periaque-ductal gray area of rats with streptozotocin-induced diabetes[J].Neurosci Lett,2003,337 (3):155-158. |
|
|
|
2024, Vol. 30 
